genomics
first
market
product
simultaneously
capture
epigenome
transcriptome
pleasanton
globe
newswire
genomics
nasdaq
txg
today
announced
begun
shipping
chromium
single
cell
multiome
atac
gene
expression
solution
customers
marking
first
commercial
release
product
capable
simultaneously
profiling
epigenome
transcriptome
single
cell
approach
provides
customers
ability
link
cell
epigenetic
program
transcriptional
output
enabling
better
understanding
cell
functionality
bypassing
need
infer
relationships
computer
simulations
one
ambitious
undertakings
company
said
ben
hindson
chief
scientific
officer
genomics
introducing
first
solution
captures
atac
gene
expression
simultaneously
researchers
gain
even
clarity
combining
two
already
powerful
methods
profile
biological
systems
single
cell
resolution
simultaneously
first
new
solution
builds
array
new
products
launched
company
year
chromium
platform
single
cell
analysis
well
visium
platform
spatial
genomics
early
customers
already
working
chromium
single
cell
multiome
atac
gene
expression
include
stanford
university
school
medicine
icahn
school
medicine
mt
sinai
spain
centro
nacional
de
an치lisis
gen칩mico
lab
interested
understanding
immune
cell
types
fail
fight
cancer
said
ansuman
satpathy
assistant
professor
pathology
stanford
university
school
medicine
plan
use
genomics
new
assay
understand
epigenetic
transcriptional
regulation
immune
cell
dysfunction
directly
patient
samples
use
information
precisely
engineer
effective
immunotherapies
relied
computational
prediction
match
cell
epigenome
gene
expression
profile
said
holger
heyn
leader
single
cell
genomics
team
spain
centro
nacional
de
an치lisis
gen칩mico
working
delineating
dynamics
underlying
differentiation
activation
genomics
new
multiome
assay
allow
us
directly
measure
could
predicted
offers
new
gold
standard
confirm
accurate
predictions
new
technology
better
understand
mechanisms
affected
risk
genetic
variation
across
wide
range
neuropsychiatric
diseases
including
alzheimer
parkinson
schizophrenia
bipolar
disorder
major
depression
along
different
severity
neuropathology
clinical
symptomatology
added
panagiotis
roussos
associate
professor
genetics
genomics
sciences
icahn
school
medicine
mount
sinai
using
chromium
single
cell
multiome
atac
gene
expression
researchers
deepen
characterization
cell
types
states
linked
transcriptional
epigenomic
analyses
discover
cells
similar
transcriptional
profiles
functionally
different
chromatin
landscapes
combine
discovery
regulatory
elements
gene
expression
explore
gene
regulatory
interactions
driving
cell
differentiation
development
disease
easily
interpret
epigenetic
profiles
key
expression
markers
maximize
insights
precious
samples
multiple
readouts
cell
chromium
single
cell
multiome
atac
gene
expression
shipping
customers
learn
visit
https
products
genomics
genomics
life
science
technology
company
building
products
interrogate
understand
master
biology
advance
human
health
company
integrated
solutions
include
instruments
consumables
software
analyzing
biological
systems
resolution
scale
matches
complexity
biology
genomics
products
adopted
researchers
around
world
including
top
global
research
institutions
top
global
pharmaceutical
companies
cited
research
papers
discoveries
ranging
oncology
immunology
neuroscience
company
patent
portfolio
comprises
issued
patents
patent
applications
forward
looking
statements
press
release
contains
statements
within
meaning
private
securities
litigation
reform
act
contained
section
securities
act
amended
section
securities
exchange
act
amended
statements
generally
identified
use
terminology
may
expect
plan
anticipate
could
intend
target
project
contemplate
believe
estimate
predict
potential
continue
negatives
terms
variations
similar
terminology
statements
include
statements
regarding
genomics
partnership
activities
involve
risks
uncertainties
could
cause
genomics
actual
results
differ
materially
anticipated
results
expectations
expressed
statements
statements
based
management
current
expectations
forecasts
beliefs
assumptions
information
currently
available
management
actual
outcomes
results
could
differ
materially
statements
due
number
factors
additional
risks
uncertainties
could
affect
genomics
financial
operating
results
cause
actual
results
differ
materially
indicated
statements
made
press
release
include
discussed
captions
risk
factors
management
discussion
analysis
financial
condition
results
operations
elsewhere
documents
genomics
files
securities
exchange
commission
time
time
statements
press
release
based
information
available
genomics
date
hereof
genomics
disclaims
obligation
update
statements
provided
reflect
change
expectations
change
events
conditions
circumstances
statement
based
except
required
law
statements
relied
upon
representing
genomics
views
date
subsequent
date
press
release
disclosure
information
genomics
uses
filings
securities
exchange
commission
website
press
releases
public
conference
calls
public
webcasts
social
media
accounts
means
disclosing
material
information
complying
disclosure
obligations
regulation
fd
